Laverock Therapeutics
Developer of a gene silencing platform designed to engineer the next generation of programmable cell therapies. The company's platform facilitates cell therapies that are both programmable and adaptiv...
Valuation
$0
Share Price
N/A
Total Raised
$27.5M
Last Round
N/A